Y-mAbs Therapeutics, Inc. - YMAB Operating profit EBITDA
The EBITDA_Co valuation displayed on GURU.Markets demonstrates that the figure stands at . Y-mAbs Therapeutics (YMAB) is implementing AI for molecule creation and robotizing drug synthesis. The business relies on proprietary antibody delivery protocols for pediatric neurosurgery. The monopoly position of the drug Danyelza in treating neuroblastoma and strict FDA oversight ensure a steady patient inflow and protection of the orphan segment.
Y-mAbs Therapeutics, Inc. - analytical breakdowns and key metrics (YMAB)
- current quotes and average value forecast:
- issuer market value details:
- book value of equity indicators:
- debt level and financial liquidity data:
- earnings and market ratios statistics:
YMAB - Company Net Income|Company Profit Forecast Y-mAbs Therapeutics|YMAB - Price to Earnings Ratio|Future Price to Earnings Multiple ymabs.com|YMAB - Price/Earnings to Growth Multiple|Enterprise Value to Operating Income Before Depreciation Ratio Y-mAbs Therapeutics|YMAB - Operating profit EBITDA|Earnings per share for the trailing year Y-mAbs Therapeutics|YMAB - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months ymabs.com|YMAB - Earnings per share growth in current year|Expected earnings per share trend next year Y-mAbs Therapeutics
Analysis of all company metrics:YMAB - Y-mAbs Corp
Analyzing the calculated EBITDA allows for an assessment of the financial stability of Y-mAbs Therapeutics (YMAB) as a reputable developer of antibodies for pediatric oncology. This indicator captures real cash flow through market trade-offs; however, acquiring the asset at the peak of the curve creates a risk of overpayment and capital freeze, which is critical for evaluating the fundamental value of a biotechnology business.
Who Y-mAbs Therapeutics competes with
ONC - Operating profit before deduction of amortization|HALO: Operating profit before deduction of amortization|RVMD - Operating profit EBITDA|Ascentage Pharma (AAPG) - Profit before payment of interest, taxes and amortization|CG Oncology Inc - Income before deduction of interest, taxes and amortization|URGN (UroGen) - Operating profit EBITDA|Profit before interest, taxes and amortization Bicara Corp BCAX|Operating profit before deduction of amortization PSNL (Personalis, Inc.)|ERAS - Profit before interest, taxes and amortization|Delcath Systems - Operating profit before deduction of amortization|Operating profit before depreciation charges Aura Biosciences Inc|CADL - Profit before payment of interest, taxes and amortization|Accuray, Inc. (ARAY) - Operating profit before deduction of amortization|SLS: Operating profit EBITDA|actuatetherapeutics.com (ACTU) - Operating profit EBITDA|CTOR (Citius Oncology) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization HURA|Profit before payment of interest, taxes and amortization Protara (TARA)|Operating income before deduction of amortization Fate Pharma|Aadi Bioscience - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization TCRX|CSBR: Operating profit before deduction of amortization|XBiotech Inc. - Company profit before taxes, interest and amortization|CVM: Operating profit EBITDA|OS Therapies, Inc. - Income before deduction of interest, taxes and amortization|RADX (Radiopharm Theranostics) - Operating profit EBITDA|Profit before interest, taxes and amortization Artiva ARTV|Profit before payment of interest, taxes and amortization Adlai Nortye Ltd. (ANL)|VERU (Veru Inc) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA TPST (Tempest Tx)|Operating profit EBITDA Xilio Therapeutics Inc XLO|RENB - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization MURA|KAPA: Operating profit EBITDA|Profit before interest, taxes and amortization OnKure Therapeutics (OKUR)|Operating profit before deduction of amortization GDTC|Operating profit EBITDA Curis Corp|Operating profit before deduction of amortization APLM (Apollomics, Inc.)|Company profit before taxes, interest and amortization THAR|Operating profit EBITDA ADVB (Advanced Biomed)|Operating income before deduction of amortization Genprex Inc. (GNPX)|Calidi Bio - Operating profit EBITDA|sunshinebiopharma.com (SBFM) - Operating profit before deduction of amortization|xeneticbio.com (XBIO) - Profit before payment of interest, taxes and amortization|SLRX - Operating income before deduction of amortization|Operating profit before deduction of amortization PPBT|Profit before interest, taxes and amortization AON AONC|Profit before payment of interest, taxes and amortization BeOne Medicines (BGNE)|Operating profit before deduction of amortization Checkpoint Therapeutics Inc CKPT|Operating profit EBITDA ELEV (Elevation Oncology)|Operating profit EBITDA iCAD Inc. ICAD|Ikena - Operating profit EBITDA|NTBL: Profit before payment of interest, taxes and amortization|VIRX: Operating profit EBITDA|Operating profit before deduction of amortization MorphoSys Corporation|NAYA (NAYA Biosciences) - Operating profit EBITDA|Operating profit EBITDA ascentage.com
